BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Lymphocyte
,
Avian flu virus
,
Phenobarbital
,
rs4950928
,
PBX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FXN
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Myeloid cells of peripheral blood
Fetal liver
Microglial cell
Liver
Hematopoietic stem cell of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Spinocerebellar ataxia
Encephalomyelopathy
Helicobacter pylori gastrointestinal tract infection
Age AND/OR growth finding
Barrett's esophagus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Hydroflumethiazide
Vaccines, DNA
flumequine
Propidium
Vaccines
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir9-3
Map3k1
SCYL3
MUTYH
LINC01719
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich'…
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia.
A modified mouse model of Friedreich's ataxia with conditional Fxn allele homozygosity delays onset …
Molecular approaches for the treatment and prevention of Friedreich's ataxia.
Friedreich's ataxia: new insights.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Characterisation of the Cognitive Profile of Patients Suffering From Friedreich's Ataxia
Biomarker for Friedreich's Ataxia (BioFridA)
Effect of Nicotinamide in Friedreich's Ataxia
Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Contribution of New Generation Oxford Nanopore-type High-throughput Sequencing in the Diagnostic Str…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ